Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
about
Emerging preclinical pharmacological targets for Parkinson's diseaseAltered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Re-engineering therapeutic antibodies for Alzheimer's disease as blood-brain barrier penetrating bi-specific antibodies.Small-molecule PET Tracers for Imaging Proteinopathies.
P2860
Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
@en
type
label
Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
@en
prefLabel
Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
@en
P2093
P2860
P1476
Targeting α-synuclein as a therapeutic strategy for Parkinson's disease.
@en
P2093
Bared Safieh-Garabedian
Nada B Lawand
Nayef E Saadé
Omar M El-Agnaf
P2860
P304
P356
10.1517/14728222.2015.1062877
P407
P577
2015-07-01T00:00:00Z